Drugs are often compounded into different dosage forms when patients cannot take the medication in its original form. However, compounded drugs are not approved by the FDA, so they may carry more risks than FDA-approved drugs. This page, published by the FDA, shares reports in which compounded drugs were associated with adverse events. It’s intended to inform health care professionals about potential dangers of compounding so that they can be more active in ensuring safe compounding. Read the cases here:
CaroSpir is the first and only FDA-approved oral suspension of the potassium-sparing diuretic spironolactone. Please visit www.CaroSpir.com to learn more.